A signal-enhanced and sensitive lateral flow aptasensor for the rapid detection of PDGF-BB. 2020

Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University Changsha China li_zhiyuan@gibh.ac.cn.

Platelet-derived growth factor BB (PDGF-BB) is a potential biomarker of tumor angiogenesis. For the first time, we developed a highly sensitive aptasensor for PDGF-BB with an enhanced test line signal by using two different gold nanoparticles (AuNPs). Herein, we describe a highly sensitive biosensor for PDGF-BB detection that combines biotinylated aptamer on a sample pad and poly thymine-Cy3-AuNP-monoclonal antibody complexes against PDGF-BB immobilized on conjugate pad A. Streptavidin (SA) and rabbit anti-mouse polyclonal antibody were also immobilized in the nitrocellulose membrane at the test and control zones, respectively. When the target PDGF-BB protein was added, it first bound the aptamer, and later the monoclonal antibody to form a biotinylated complex that was captured by SA, resulting in a visual red line on the test zone. In addition, to enhance the sensitivity, another monoclonal antibody against Cy3 was conjugated on AuNP B and immobilized on conjugate pad B to form a AuNPs (A&B)-antibody-(PDGF-BB-Cy3)-aptamer-biotin-SA complex on the test line when a loading buffer was subsequently added. This approach showed a linear response to PDGF-BB from 3 ng mL-1 to 300 ng mL-1 with a limit of detection as low as 1 ng mL-1 obtained in 10 minutes. Our biosensor displayed results through red lines readable by the naked eye. Interestingly, our approach has been successfully applied for real sample verification, proving its applicability for cancer monitoring and diagnosis.

UI MeSH Term Description Entries

Related Publications

Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
February 2019, Molecules (Basel, Switzerland),
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
April 2020, Talanta,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
September 2022, The Analyst,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
March 2013, The Analyst,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
May 2024, ACS omega,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
February 2021, The Analyst,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
December 2018, Food chemistry,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
April 2021, RSC advances,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
July 2022, Biosensors & bioelectronics,
Na Cheng, and Yujie Liu, and Omar Mukama, and Xiaobo Han, and Hualin Huang, and Shuai Li, and Peng Zhou, and Xuewen Lu, and Zhiyuan Li
May 2023, The Analyst,
Copied contents to your clipboard!